Clinical Trial Update: Reveal the Level of Anxiety in Patients With Crohn's Disease Receiving Adalimumab

View source ↗

Summary

This completed clinical trial assessed anxiety levels in patients with severe Crohn's disease treated with adalimumab; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Severe Crohn's Disease, Anxiety | Status: COMPLETED | Results posted: 2014-11-03